Q2 2024 Editas Medicine Inc Earnings Call Transcript
Good morning and welcome to the Editas Medicine second quarter 2024 conference call. (Operator Instructions) Please note, this call is being recorded at the company's request. I'd like to turn the call over to Christy Barnhart, Corporate Communications and Investor Relations at Editas Medicine.
Thank you, Britney. Good morning, everyone, and welcome to our second quarter 2024 conference call. Earlier this morning, we issued a press release providing our financial results and recent corporate updates. A replay of today's call will be available in the Investors section of our website approximately two hours after its completion.
After our prepared remarks, we will open the call for Q&A. As a reminder, various remarks that we make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |